Stock Rich List
#729 on the corporate holders of 813 holders

Rosalind Advisors, Inc.

Director at Delcath Systems.

$65.2M
in disclosed stock, −$1.6M (−2.34%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
729th of 813
Companies held
1
Largest holding
DCTH, 100.0% of total
Latest SEC filing
Oct 13, 2026

What the $65.2M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Delcath Systems DCTH
Common Stock
Through Rosalind Advisors Inc., the advisor to the Rosalind Funds3,389,593$19.24$65.2M100.0%Form 4, Oct 13, 2026

Share counts are the amounts Rosalind Advisors, Inc. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
726RA Capital Healthcare Fund LP
Director, Tyra Biosciences
$66.4M+$1.0M (+1.59%)
727Alyeska Investment Group, L.P.
10% owner, FrontView REIT
$66.3M−$858K (−1.28%)
728Pioneer Acquisition 1 Sponsor Holdco LLC
10% owner, Pioneer Acquisition I
$65.9M$0 (0.00%)
729Rosalind Advisors, Inc.
Director, Delcath Systems
$65.2M−$1.6M (−2.34%)
730venBio Global Strategic Fund IV, L.P.
10% owner, Attovia Therapeutics
$65.1M+$209K (+0.32%)
731Biotechnology Value Trading Fund OS LP
Director, Kymera Therapeutics
$64.4M−$816K (−1.25%)
732Transcontinental Realty Investors INC
10% owner, Income Opportunity Realty Investors
$64.0M$0 (0.00%)

Other Delcath Systems insiders

All DCTH insiders

Questions

How much stock does Rosalind Advisors, Inc. own?

Rosalind Advisors, Inc. holds $65,215,769 in listed stock based on SEC filings and current prices, mostly Delcath Systems (DCTH). That ranks 729th on the Stock Rich List.

Is this Rosalind Advisors, Inc.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

Files jointly with Steven Salamon, Gil Aharon.